CIRCLES
Improving The Quality, Accessibility And Value of Research
Hundreds of billions of dollars are spent annually on medical research. Some measures suggest a satisfactory return on that investment – articles published, issued patents, foundation dollars raised, new drugs. Conversely, declining healthcare metrics for broad population groups suggest a more disappointing picture.
Through Circles, medical research can be far less costly and far more efficient. Resulting advances can have greater impact sooner, and for broader patient populations. Circles drive deeper collaboration among clinicians, scientists, and industry. That collaboration generates substantial amounts of real-world evidence, which is ultimately the most important category of healthcare data for medical research.
The Strategic Importance Of Real-World Evidence
Real-world evidence (RWE) is essential to achieving healthcare’s most pressing goals – value-based care, health equity and controlling costs. It accelerates advances in medical science, and helps bring them to broader patient populations more efficiently. It is necessary to establishing the long-term safety and efficacy of medical products and treatment protocols.
RWE is not electronic medical record data, which focuses on reimbursement. It is not data from traditional clinical trials, which are lengthy, expensive and exclude major patient segments. Rather, RWE is based on the validated, longitudinal and contextually correlated data arising from everyday clinical interventions. RWE is to be found in the real world, and has profound implications for healthcare in the real world.
What We Do
We license the patented cloud-based software platform necessary to capture, aggregate, analyze and use RWE. That platform integrates the powerful user experience of inCytes™ for physicians and Benchmarc™ for their patients.
We also provide the processes enabling physicians and industry to generate clinical, professional and financial value from RWE with minimal burden.
Circles-based RWE solutions are turnkey, flexible, and cost effective. They are tailored to the strategic objectives of our clients, and deliver demonstrable and sustained return on investment. They represent a profit center, not a cost center.
Whom We Support
Real-world evidence can materially advance the strategic objectives of providers, product manufacturers, payers (including self-insured employers), medical societies, researchers, foundations, and patient advocacy groups.
We have developed Circles-based RWE solutions for each of these client categories around the world. The flexibility and low cost of Circles allow us to work with clients of any size.
Engaging With Us
We make it simple to begin, scale, modify or terminate a contractual relationship. Pricing and terms are transparent, with no commitment beyond thirty days.
The first step can be as simple as Joining a Circle, at only $35 per month and $5 per Case. This is an excellent way to begin appreciating the potential of proprietary Circles, as well as strategically impactful Circles-based RWE programs.
In all cases, we work as a long-term partner with our clients. We take the time to understand their objectives, agree on key metrics, and jointly design and execute a real-world evidence solution which generates sustainable strategic value.
Testimonials
“We partnered with RegenMed over a year ago to collect real-world data by using RegenMed’s Circles Program in order to collect data that can be used to provide evidence, more than trends only.
Our goal is ultimately to have clear cut evidence what optimal preparation methods and protocols are to facilitate physicians in optimizing their treatment strategies, using a variety of highly efficient and reproducible protocols.
The platform has accommodated our highly specific research objectives, customer engagement and feedback has been overwhelmingly positive, and we have already generated valuable, statistically significant data for up to 1 year, clearly leading us to further refinement of our protocols.”
“The field of regenerative medicine remains growing, both in size and in need for evidence-based standards. ROSM has long been a pioneer of non-surgical treatment options, and that leadership will now extend to the generation and dissemination of real-world evidence across a growing number of protocols, products, and patient populations.
RegenMed shared our strategic vision, and with its turnkey platforms and deep regenerative medicine experience, was the natural partner to help us design and expand this broad initiative.”
“The Circles platform is very user friendly. The system is completely automated so that the reminders come to the patients, who fill in the data, which then comes to us directly for our analysis. We are able to establish a very good percentage of participation amongst our patients.
I want objective numbers I can share with patients. It is also important for me to be able to share my outcomes with my colleagues. Finally, I want to collect these categories of data since we are in a field facing increased regulatory oversight.”
“Breakthrough Regenerative Orthopedics is proud to partner with RegenMed to collect real world evidence on treating SI dysfunction and ligamentous laxity. RegenMed has become our go-to partner for clinical data collection based on their commitment to user-friendly, customer-focused data collection solutions for busy clinicians like ourselves.”
“I am excited to be working with RegenMed in executing the RWE Program. This will help to expand Summus’ clinical and scientific correlations and reach a broader team of providers to collect valuable data.”
“We look forward to unlocking new frontiers of innovation and patient care through the RWE Program. Collaborating with RegenMed presents an invaluable opportunity to accelerate and push the limits of laser therapy and its capabilities, ultimately advancing medical science and enhancing patient outcomes.”